Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF)

被引：0
|
作者：
Masseria, C. [1 ]
Lin, I. [2 ]
Mardekian, J. [1 ]
Frean, M. [2 ]
Phatak, H. [3 ]
Kamble, S. [3 ]
Unniachan, S. [3 ]
Petkun, W. [3 ]
Abdulsattar, Y. [1 ]
Lip, G. Y. H. [4 ]
机构：
[1] Pfizer Inc, New York, NY USA
[2] Boston Hlth Econ, Waltham, MA USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Univ Birmingham, Birmingham, W Midlands, England
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6212
引用
收藏
页码：1084 / 1084
页数：1
相关论文
共 50 条
  • [1] Non-valvular atrial fibrillation (NVAF)
    Roderick, E
    Cox, J
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 1997, 47 (423): : 660 - 661
  • [2] Reasons for discontinuation of direct oral anticoagulant therapy in patients with non-valvular atrial fibrillation
    Renner, Elizabeth
    Mouland, Erin
    Saad, Samira
    Ha, Nghi
    Kim, Pauline
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 617 - 618
  • [3] Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation
    Mehmet Agirbasli
    [J]. Journal of Thrombosis and Thrombolysis, 2018, 46 : 570 - 570
  • [4] Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation
    Agirbasli, Mehmet
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (04) : 570 - 570
  • [5] Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy
    Zhen, Simon
    Chu, Fion
    Kodesh, Afek
    Kim, Jisoon
    [J]. BMJ CASE REPORTS, 2024, 17 (01)
  • [6] Long-Term Oral Anticoagulant Management Associated with Routine Medical Care (RMC) In Patients with Non-Valvular Atrial Fibrillation (NVAF) In Canada
    Selby, Rita
    Mittmann, Nicole
    Isogai, Pierre K.
    Kaus, Lisa
    Koo, Marika
    Sealey, Faith
    [J]. BLOOD, 2011, 118 (21) : 1793 - 1793
  • [7] Long-term oral anticoagulant management associated with routine medical care (RMC) in patients with non-valvular atrial fibrillation (NVAF) in Canada
    Selby, R.
    Mittmann, N.
    Isogai, P.
    Kaus, L.
    Koo, M.
    Sealey, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 688 - 688
  • [8] CAUSES OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL-FIBRILLATION (NVAF)
    BOGOUSSLAVSKY, J
    VANMELLE, G
    REGLI, F
    KAPPENBERGER, L
    [J]. STROKE, 1990, 21 (01) : 174 - 174
  • [9] Patient with non-valvular atrial fibrillation on ineffective anticoagulant therapy
    Kot, Anna
    Starzyk, Katarzyna
    Dobaj, Lukasz
    Bakowski, Dawid
    Wozakowska-Kaplon, Beata
    [J]. KARDIOLOGIA POLSKA, 2016, 74 : 52 - 54
  • [10] Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis
    Azza AbuDagga
    Judith J Stephenson
    An-Chen Fu
    Winghan Jacqueline Kwong
    Hiangkiat Tan
    William S Weintraub
    [J]. BMC Health Services Research, 14
12345